We are live on ! Find out more
UBS AM

UBS AM Portfolio holdings

AUM $481B
1-Year Est. Return 26.39%
 

UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
-12.37%
1 Year Est. Return
+26.39%
3 Year Est. Return
+93.76%
5 Year Est. Return
+124.47%
10 Year Est. Return
+503.87%
AUM
$116B
AUM Growth
-$18.5B
Cap. Flow
-$576M
Cap. Flow %
-0.5%
Top 10 Hldgs %
17.33%
Holding
2,899
New
140
Increased
1,359
Reduced
845
Closed
130

Sector Composition

Rank Sector Weight
1 Technology 17.47%
2 Healthcare 14.9%
3 Financials 14.08%
4 Consumer Discretionary 11.32%
5 Communication Services 8.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IPHS
2801
DELISTED
Innophos Holdings, Inc.
IPHS
-4,739
Closed -$210K
CBLK
2802
DELISTED
Carbon Black, Inc. Common Stock
CBLK
-43,800
Closed -$928K
TOWR
2803
DELISTED
Tower International, Inc.
TOWR
-7,100
Closed -$215K
AMR
2804
DELISTED
Alta Mesa Resources Inc
AMR
-28,100
Closed -$117K
BRSS
2805
DELISTED
Global Brass & Copper Hldgs, Inc
BRSS
-5,700
Closed -$210K
AKAO
2806
DELISTED
Achaogen Inc
AKAO
-30,496
Closed -$122K
SGYP
2807
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
-80,394
Closed -$137K
ELGX
2808
DELISTED
Endologix Inc
ELGX
-7,450
Closed -$142K
HES.PRA
2809
DELISTED
Hess Corporation
HES.PRA
-36
Closed -$2.86K
ECYT
2810
DELISTED
Endocyte, Inc. Common Stock
ECYT
-27,500
Closed -$488K
XOXO
2811
DELISTED
Xo Group Inc
XOXO
-17,798
Closed -$614K
ESRX
2812
DELISTED
Express Scripts Holding Company
ESRX
-2,572,443
Closed -$244M
EEQ
2813
DELISTED
Enbridge Energy Management Llc
EEQ
-61,963
Closed -$677K
KERX
2814
DELISTED
Keryx Biopharmaceuticals Inc
KERX
-65,734
Closed -$223K
OCLR
2815
DELISTED
Oclaro Inc.
OCLR
-84,006
Closed -$751K
FCE.A
2816
DELISTED
Forest City Realty Trust, Inc.
FCE.A
-702,142
Closed -$17.6M
SONC
2817
DELISTED
Sonic Corp
SONC
-24,999
Closed -$1.08M
SODA
2818
DELISTED
SodaStream International Ltd
SODA
-10,000
Closed -$1.43M
MITL
2819
DELISTED
Mitel Networks Corporation
MITL
-59,072
Closed -$651K
LHO
2820
DELISTED
LaSalle Hotel Properties
LHO
-348,400
Closed -$12.1M
AFSI
2821
DELISTED
AmTrust Financial Services, Inc.
AFSI
-87,170
Closed -$1.27M
EGN
2822
DELISTED
Energen
EGN
-89,232
Closed -$7.69M
AET
2823
DELISTED
Aetna Inc
AET
-1,668,728
Closed -$339M
COL
2824
DELISTED
Rockwell Collins
COL
-575,031
Closed -$80.8M
KMG
2825
DELISTED
KMG Chemicals Inc
KMG
-3,500
Closed -$264K

Similar funds

UBS AM's Q4 2018 Portfolio in Review

As of Q4 2018, UBS AM held 2,899 positions worth $116B, down 14% from $135B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

UBS AM's Q4 2018 filing shows 140 new, 1,359 increased, 845 reduced and 130 closed positions. Its largest new stake was Linde: 1,823,057 shares worth $284M. The largest sale was Aetna Inc, an estimated $339M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.

  • UBS AM's largest Q4 2018 buy was Linde: 1,823,057 shares worth $284M.
  • UBS AM added most to iShares US Treasury Bond ETF in Q4 2018, an estimated $215M increase.
  • UBS AM's biggest Q4 2018 reduction was Meta Platforms (Facebook), cutting an estimated $182M.
  • UBS AM fully exited Aetna Inc in Q4 2018, selling an estimated $339M.
  • UBS AM's ten largest holdings make up 17% of its $116B portfolio in Q4 2018.
  • UBS AM opened 140 new positions and closed 130 in Q4 2018.
  • UBS AM's portfolio value fell 14% quarter-over-quarter to $116B.

Based on UBS AM's 13F filing for Q4 2018, filed 13 Feb 2019.